Case report shows novel disease presentation in SM patient
A recently-published case report highlights the importance of adequate tissue sampling when evaluating for SM, researchers wrote.
News
-
-
SM therapy shows promise in phase 2 trial
New data shows over half of patients in a phase 2 study of an investigational SM therapy saw improvement in severe SM-associated symptoms.
-
Type 1 interferon autoantibodies not linked to development of SM
Researchers of a recently-published study found autoantibodies to type I [IFN] do not affect the pathogenesis or manifestations of SM.
Learn more about SM
Sign up for the latest news, perspectives, and information about SM.
